# FDA Inspection 1239875 - Xiamen LP Pharmaceutical Co., Ltd. - April 19, 2024

Source: https://www.keypedia.com/records/fda_inspections/xiamen-lp-pharmaceutical-co-ltd/b93b0ea9-adda-4d3d-babf-0d5e2037c518
Source feed: FDA_Inspections

> FDA Inspection 1239875 for Xiamen LP Pharmaceutical Co., Ltd. on April 19, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1239875
- Company Name: Xiamen LP Pharmaceutical Co., Ltd.
- Inspection Date: 2024-04-19
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1266509 - 2025-02-28](https://www.keypedia.com/records/fda_inspections/xiamen-lp-pharmaceutical-co-ltd/ce6ee8ba-2412-4ae2-872e-bcec2a439225)
- [FDA Inspection 1072549 - 2018-11-16](https://www.keypedia.com/records/fda_inspections/xiamen-lp-pharmaceutical-co-ltd/d185c543-5c1d-4278-a21e-0f17a0b003e5)

Company: https://www.keypedia.com/companies/xiamen-lp-pharmaceutical-co-ltd/fb23c997-3591-4cab-a4f2-17802b76cb23

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c